271 related articles for article (PubMed ID: 15721402)
21. Single-dose methotrexate regimen in the treatment of low-risk gestational trophoblastic neoplasia.
Chan KK; Huang Y; Tam KF; Tse KY; Ngan HY
Am J Obstet Gynecol; 2006 Nov; 195(5):1282-6. PubMed ID: 16723109
[TBL] [Abstract][Full Text] [Related]
22. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
Homesley HD
J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
[TBL] [Abstract][Full Text] [Related]
23. Treatment results of methotrexate and folinic acid as primary chemotherapy for nonmetastatic gestational trophoblastic neoplasia.
Srisomboon J; Suprasert P; Phongnarisorn C; Charoenkwan K; Siriaree S; Cheewakriangkrai C; Tantipalakorn C; Kietpeerakool C
J Med Assoc Thai; 2005 Jul; 88(7):886-90. PubMed ID: 16241014
[TBL] [Abstract][Full Text] [Related]
24. Actinomycin D for methotrexate-failed low-risk gestational trophoblastic neoplasia.
Lurain JR; Chapman-Davis E; Hoekstra AV; Schink JC
J Reprod Med; 2012; 57(7-8):283-7. PubMed ID: 22838241
[TBL] [Abstract][Full Text] [Related]
25. Management of low-risk gestational trophoblastic tumors with etoposide (VP16) in patients resistant to methotrexate.
Mangili G; Garavaglia E; Frigerio L; Candotti G; Ferrari A
Gynecol Oncol; 1996 May; 61(2):218-20. PubMed ID: 8626136
[TBL] [Abstract][Full Text] [Related]
26. Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia.
Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS
Gynecol Oncol; 2009 Feb; 112(2):353-7. PubMed ID: 19059633
[TBL] [Abstract][Full Text] [Related]
27. Management of brain metastases in patients with high-risk gestational trophoblastic tumors.
Newlands ES; Holden L; Seckl MJ; McNeish I; Strickland S; Rustin GJ
J Reprod Med; 2002 Jun; 47(6):465-71. PubMed ID: 12092015
[TBL] [Abstract][Full Text] [Related]
28. Methotrexate, bleomycin, and Etoposide in the treatment of gestational trophoblastic neoplasia.
Ngan HY; Tam KF; Lam KW; Chan KK
Obstet Gynecol; 2006 May; 107(5):1012-7. PubMed ID: 16648404
[TBL] [Abstract][Full Text] [Related]
29. Clinical epidemiology and management of gestational trophoblastic neoplasia in Hungary in the past 34 years.
Fülöp V; Szigetvári I; Szepesi J; Végh G; Singh M; Berkowitz RS
J Reprod Med; 2012; 57(7-8):310-8. PubMed ID: 22838247
[TBL] [Abstract][Full Text] [Related]
30. Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors.
Matsui H; Suzuka K; Iitsuka Y; Seki K; Sekiya S
Gynecol Oncol; 2000 Jul; 78(1):28-31. PubMed ID: 10873405
[TBL] [Abstract][Full Text] [Related]
31. Methotrexate for 2000 FIGO low-risk gestational trophoblastic neoplasia patients: efficacy and toxicity.
Chalouhi GE; Golfier F; Soignon P; Massardier J; Guastalla JP; Trillet-Lenoir V; Schott AM; Raudrant D
Am J Obstet Gynecol; 2009 Jun; 200(6):643.e1-6. PubMed ID: 19393597
[TBL] [Abstract][Full Text] [Related]
32. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
[TBL] [Abstract][Full Text] [Related]
33. Management of resistant gestational trophoblastic tumors.
Newlands ES; Bower M; Holden L; Short D; Seckl MJ; Rustin GJ; Begent RH; Bagshawe KD
J Reprod Med; 1998 Feb; 43(2):111-8. PubMed ID: 9513872
[TBL] [Abstract][Full Text] [Related]
34. EMA/EP chemotherapy for chemorefractory gestational trophoblastic tumor.
Xiang Y; Sun Z; Wan X; Yang X
J Reprod Med; 2004 Jun; 49(6):443-6. PubMed ID: 15283051
[TBL] [Abstract][Full Text] [Related]
35. Management of metastatic high-risk gestational trophoblastic neoplasia: FIGO stages II-IV: risk factor score > or = 7.
Lurain JR; Singh DK; Schink JC
J Reprod Med; 2010; 55(5-6):199-207. PubMed ID: 20626175
[TBL] [Abstract][Full Text] [Related]
36. Comparison of chemotherapies with methotrexate, VP-16 and actinomycin-D in low-risk gestational trophoblastic disease. Remission rates and drug toxicities.
Matsui H; Iitsuka Y; Seki K; Sekiya S
Gynecol Obstet Invest; 1998; 46(1):5-8. PubMed ID: 9692333
[TBL] [Abstract][Full Text] [Related]
37. Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease.
Soper JT; Evans AC; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
Obstet Gynecol; 1994 Jan; 83(1):113-7. PubMed ID: 8272290
[TBL] [Abstract][Full Text] [Related]
38. [Combination chemotherapy with etoposide and cisplatin for high-risk, chemorefractory and recurrent gestational trophoblastic neoplasia].
Jiang J; Nan FF; Yang XS; Zhang YZ; Wang B; Kong BH
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):595-9. PubMed ID: 17983513
[TBL] [Abstract][Full Text] [Related]
39. Recurrent gestational trophoblastic tumor: management and risk factors for recurrence.
Yang J; Xiang Y; Wan X; Yang X
Gynecol Oncol; 2006 Nov; 103(2):587-90. PubMed ID: 16750258
[TBL] [Abstract][Full Text] [Related]
40. Importance of salvage therapy in the management of high-risk gestational trophoblastic neoplasia.
Lurain JR; Schink JC
J Reprod Med; 2012; 57(5-6):219-24. PubMed ID: 22696816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
